___

• 1. Fox RI. Sjögren’s syndrome. Lancet (London, England) 2005;366:321-31.
• 2. Lam QL, Lu L. Role of leptin in immunity. Cellular & molecular immunology. 2007;4:1-13.
• 3. Chung CP, Long AG, Solus JF, Rho YH, Oeser A, Raggi P, et al. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 2009;18:799-806.
• 4. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Muñoz EG, Salazar-Paramo M, González-Ortiz M, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatology international 2002;22:138-41.
• 5. Bohlender J, Rauh M, Zenk J, Gröschl M. Differential distribution and expression of leptin and the functional leptin receptor in major salivary glands of humans. The Journal of endocrinology 2003;178:217-23.
• 6. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis care & research 2012;64:475-87.
• 7. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A et al. EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Annals of the Rheumatic Diseases 2010;69:1103-1109.
• 8. Erbasan F, Alikanoğlu AS, Yazısız V, Karasu U, Balkarlı A, et al. Leptin and leptin receptors in salivary glands of primary Sjögren’s syndrome. Pathology, research and practice 2016;212:1010-4.